Literature DB >> 17191384

CD28 and CD27 costimulation of CD8+ T cells: a story of survival.

Douglas V Dolfi1, Peter D Katsikis.   

Abstract

Although the requirement of CD28 and CD27 costimulation has been clearly demonstrated during primary CD8+ T cell responses and this costimulation acts by providing proliferation and survival cues to naive CD8+ T cells, a number of questions also arise from these studies. Is the requirement for CD28 and CD27 costimulation restricted to the initiation of the immune response in the lymph nodes, where presumably the initial contact between naive CD8+ T cell and DC occurs? What is the purpose of the dramatic influx of DC to sites of inflammation such as the lung during influenza virus infection and the formation of inflammatory BALT (iBALT)?(104) Are such DC at the site of inflammation and at later stages of the immune response providing cytokines or costimulation to effector CD8+ T cells? If DC are required for optimal secondary responses (100), is CD28 costimulation the missing signal or is it other members of the B7:CD28 family or TNF family? Given that a number of investigators are actively addressing these questions, the answers we expect will be soon to come and open exciting new opportunities for immune enhancement or dampening strategies and vaccine adjuvants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17191384     DOI: 10.1007/978-0-387-34814-8_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticles.

Authors:  Ruhi V Ubale; Rikhav P Gala; Susu M Zughaier; Martin J D'Souza
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

2.  IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection.

Authors:  Jodi McGill; Nico Van Rooijen; Kevin L Legge
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

3.  Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis.

Authors:  Monika Manocha; Svend Rietdijk; Rietdijk Svend; Amale Laouar; Gongxian Liao; Atul Bhan; Jannie Borst; Jannine Borst; Cox Terhorst; N Manjunath
Journal:  J Immunol       Date:  2009-06-12       Impact factor: 5.422

Review 4.  CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation.

Authors:  Thomas Hünig; Fred Lühder; Karin Elflein; Tea Gogishvili; Monika Fröhlich; Reto Guler; Antony Cutler; Frank Brombacher
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 3.402

5.  Late engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3+ regulatory T cell dependent manner.

Authors:  Emily K Moser; Matthew M Hufford; Thomas J Braciale
Journal:  PLoS Pathog       Date:  2014-08-21       Impact factor: 6.823

Review 6.  Markers of T Cell Senescence in Humans.

Authors:  Weili Xu; Anis Larbi
Journal:  Int J Mol Sci       Date:  2017-08-10       Impact factor: 5.923

7.  Maternal-Fetal rejection reactions are unconstrained in preeclamptic women.

Authors:  Tina A Nguyen; Daniel A Kahn; Andrea I Loewendorf
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

Review 8.  Recognition of self and altered self by T cells in autoimmunity and allergy.

Authors:  Lei Yin; Shaodong Dai; Gina Clayton; Wei Gao; Yang Wang; John Kappler; Philippa Marrack
Journal:  Protein Cell       Date:  2013-01-11       Impact factor: 14.870

Review 9.  Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.

Authors:  Ilse Van Brussel; Zwi N Berneman; Nathalie Cools
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.